Glass House Brands (GLAS) Cash & Equivalents (2020 - 2026)

Glass House Brands' (GLAS) quarterly Cash & Equivalents came in at $27.9 million in Q1 2026, down 25.76% year-on-year from $37.6 million in Q1 2025, and up 40.69% on a QoQ basis from $19.8 million in Q4 2025.

Glass House Brands (GLAS) Cash & Equivalents (2020 - 2026) Analysis & Trends

Glass House Brands (GLAS) has 7 years of Cash & Equivalents data on file, last reported at $27.9 million in Q1 2026.

  • On a quarterly basis, Cash & Equivalents fell 25.76% year-over-year to $27.9 million in Q1 2026; TTM through Mar 2026 was $27.9 million, a 25.76% decrease from a year earlier, with the FY2025 full-year figure at $19.8 million, down 41.49% from the prior year.
  • Cash & Equivalents for Q1 2026 stood at $27.9 million, up from $19.8 million in the prior quarter.
  • Over the last five years, Cash & Equivalents for GLAS reached as high as $44.2 million in Q2 2025 and fell as low as $11.1 million in Q4 2022.
  • Historically, Cash & Equivalents has averaged $26.8 million across 5 years, with a median of $25.9 million in 2024.
  • Across the five-year window, Cash & Equivalents plunged 93.34% in 2022 and surged 164.94% in 2023, its largest moves.
  • Year by year, Cash & Equivalents stood at $11.1 million in 2022, then jumped by 164.94% to $29.5 million in 2023, then increased by 14.9% to $33.9 million in 2024, then slumped by 41.49% to $19.8 million in 2025, then soared by 40.69% to $27.9 million in 2026.
  • Per Business Quant data, the three most recent Cash & Equivalents figures were $27.9 million in Q1 2026, $19.8 million in Q4 2025, and $29.8 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. (Qtr)
1 Haleon 89.28 Bn 87.42 Bn - 1.76 Bn
2 Teva Pharmaceutical Industries 35.97 Bn 32.23 Bn 1.97 Bn 3.74 Bn
3 Zoetis 32.42 Bn 30.48 Bn 1.62 Bn 1.94 Bn
4 Takeda Pharmaceutical 27.48 Bn 23.42 Bn 4.39 Bn 3.79 Bn
5 United Therapeutics 22.89 Bn 20.73 Bn 648.10 Mn 1.28 Bn
6 RedHill Biopharma 22.11 Bn 22.11 Bn - 3.97 Mn
7 Viatris 20.44 Bn 18.64 Bn 1.16 Bn 1.80 Bn
8 Neurocrine Biosciences 17.76 Bn 16.44 Bn 800.70 Mn 266.50 Mn
9 Elanco Animal Health 12.62 Bn 12.19 Bn 785.00 Mn 428.00 Mn
10 Glass House Brands 873.84 Mn 845.91 Mn 10.02 Mn 27.93 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 27.93 Mn
Dec 31, 2025 19.85 Mn
Sep 30, 2025 29.77 Mn
Jun 30, 2025 44.20 Mn
Mar 31, 2025 37.62 Mn
Dec 31, 2024 33.92 Mn
Sep 30, 2024 35.06 Mn
Jun 30, 2024 25.88 Mn
Mar 31, 2024 24.41 Mn
Dec 31, 2023 29.52 Mn
Sep 30, 2023 37.89 Mn
Jun 30, 2023 22.69 Mn
Mar 31, 2023 16.37 Mn
Dec 31, 2022 11.14 Mn
Sep 30, 2022 17.54 Mn
Jun 30, 2022 17.45 Mn
Mar 31, 2022 24.83 Mn
Dec 31, 2021 51.07 Mn
Sep 30, 2021 28.86 Mn
Jun 30, 2021 134.28 Mn